Corxel
PrivateLast Round
Series D
Extension
Jan 22, 2026
Total Funding Raised
$489M
Company Overview
Corxel is a biopharmaceutical company that in-licenses and develops clinical-stage assets to treat cardiometabolic and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Corxel Comparables
Compare Corxel with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zhejiang Jixing Auto Parts Co., Ltd. | 97% | |
| Gmax Biopharm | 81% | |
| Sciwind Biosciences | 80% |
Corxel Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Jan 22, 2026 | ||||
| Series D | Jan 6, 2024 | ||||
| Series C | Sep 1, 2021 | ||||
| Series B | Jul 13, 2021 |
Corxel Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hengdian Group Capital | Series D Extension |
| SymBiosis Capital Management | Series D Extension |
| RA Capital Management | Series D Extension |
| TCG Crossover | Series D Extension |
| HBM Healthcare Investments | Series D Extension |
| Adage Capital Management | Series D Extension |
| SilverArc Capital Management | Series D Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2024
$162M round led by Leaps by Bayer and RTW Investments.
Corxel Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Corxel's valuation, stock price, and market status.
Is Corxel a public or private company?
Corxel is a private company.
What is the current stock price of Corxel?
Corxel is a private company with no public stock price. No recent secondary market data is available.
How much is Corxel worth (valuation)?
Valuation information for Corxel is not publicly available.
Can I buy Corxel stock?
Corxel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Corxel's last funding round?
Corxel's most recent funding round was Series D Extension on January 22, 2026.
Who are the main investors in Corxel?
Key investors in Corxel include RTW Investments, Leaps by Bayer.
Will Corxel IPO soon?
No public IPO plans have been announced for Corxel.
How can I track Corxel secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Corxel's secondary market activity and sign up for updates.